RGRYX
Price
$39.45
Change
-$0.09 (-0.23%)
Updated
Dec 3 closing price
Net Assets
383.86M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

RGRYX vs VIGRX

Header iconRGRYX vs VIGRX Comparison
Open Charts RGRYX vs VIGRXBanner chart's image
Victory RS Growth Y
Price$39.45
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets383.86M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
RGRYX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
RGRYX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGRYX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. RGRYX (384M). VIGRX pays higher dividends than RGRYX: VIGRX (0.30) vs RGRYX (0.00). RGRYX was incepted earlier than VIGRX: RGRYX (19 years) vs VIGRX (33 years). RGRYX (0.98) is less costly to investors than VIGRX (0.17). RGRYX is a more actively managed with annual turnover of: 50.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than RGRYX: VIGRX (3000) vs RGRYX (1000000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. RGRYX (9.98). VIGRX return over 5 years is better than : 99.11 vs. RGRYX (49.34).
RGRYXVIGRXRGRYX / VIGRX
Total Expense Ratio0.830.17488%
Annual Report Gross Expense Ratio0.980.17576%
Fund Existence19 years33 years-
Gain YTD18.96919.76496%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets384M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year9.9818.4954%
Returns for 3 years95.78110.8286%
Returns for 5 years49.3499.1150%
Returns for 10 years102.54349.1329%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT